BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma
Background. Stimulated thyroglobulin levels measured at the time of remnant ablation (A-hTg) and BRAFV600E mutation had shown prognostic value in predicting persistent disease in differentiated thyroid cancer (DTC). The aim of this study was to evaluate the prognostic role of A-hTg combined with the...
Saved in:
| Main Authors: | Andrea Repaci, Valentina Vicennati, Alexandro Paccapelo, Ottavio Cavicchi, Nicola Salituro, Fabio Monari, Dario de Biase, Giovanni Tallini, Annalisa Altimari, Elisa Gruppioni, Michelangelo Fiorentino, Uberto Pagotto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2019/3081497 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Two Cases of Armour Thyroid Interference in Thyroglobulin Monitoring for Thyroid Cancer
by: Michelle Ponder, et al.
Published: (2021-01-01) -
THE ROLE OF BRAF V600E IN THE DEVELOPMENT OF THYROID CANCER PHENOTYPE: A SYSTEMATIC REVIEW
by: Pratia Mega, et al.
Published: (2025-01-01) -
Thyroglobulin Gene Mutation with Cold Nodule on Thyroid Scintigraphy
by: Toshio Kahara, et al.
Published: (2012-01-01) -
RESULTS OF RESEARCH OF GALECTIN-3 AND THYROGLOBULIN IN PATIENTS WITH THYROID NODULES
by: O. S. Olifirova, et al.
Published: (2015-04-01) -
BRAF in Papillary Thyroid Carcinoma
by: Salvatore Giovanni Lanzilotta, et al.
Published: (2007-01-01)